Related Experiment Video
Updated: Jun 24, 2026

Investigation of Macrophage Polarization Using Bone Marrow Derived Macrophages
Published on: June 23, 2013
Alternatively activated macrophage-derived RELM-{alpha} is a negative regulator of type 2 inflammation in the lung
Meera G Nair1, Yurong Du, Jacqueline G Perrigoue
1Department of Pathobiology, University of Pennsylvania, Philadelphia, 19104, USA.
Abstract:
Differentiation and recruitment of alternatively activated macrophages (AAMacs) are hallmarks of several inflammatory conditions associated with infection, allergy, diabetes, and cancer. AAMacs are defined by the expression of Arginase 1, chitinase-like molecules, and resistin-like molecule (RELM) alpha/FIZZ1; however, the influence of these molecules on the development, progression, or resolution of inflammatory diseases is unknown. We describe the generation of RELM-alpha-deficient (Retnla(-/-)) mice and use a model of T helper type 2 (Th2) cytokine-dependent lung inflammation to identify an immunoregulatory role for RELM-alpha. After challenge with Schistosoma mansoni (Sm) eggs, Retnla(-/-) mice developed exacerbated lung inflammation compared with their wild-type counterparts, characterized by excessive pulmonary vascularization, increased size of egg-induced granulomas, and elevated fibrosis. Associated with increased disease severity, Sm egg-challenged Retnla(-/-) mice exhibited elevated expression of pathogen-specific CD4(+) T cell-derived Th2 cytokines. Consistent with immunoregulatory properties, recombinant RELM-alpha could bind to macrophages and effector CD4(+) Th2 cells and inhibited Th2 cytokine production in a Bruton's tyrosine kinase-dependent manner. Additionally, Retnla(-/-) AAMacs promoted exaggerated antigen-specific Th2 cell differentiation. Collectively, these data identify a previously unrecognized role for AAMac-derived RELM-alpha in limiting the pathogenesis of Th2 cytokine-mediated pulmonary inflammation, in part through the regulation of CD4(+) T cell responses.
Insights
Resistin-like molecule alpha (RELM-alpha) limits lung inflammation by regulating T helper 2 cell responses. RELM-alpha deficiency in alternatively activated macrophages exacerbates allergic lung inflammation and fibrosis.
Area of Science:
- Immunology
- Inflammation research
- Macrophage biology
Background:
- Alternatively activated macrophages (AAMacs) are key in inflammatory diseases.
- Molecules like resistin-like molecule alpha (RELM-alpha) define AAMacs, but their role in disease is unclear.
- RELM-alpha's influence on inflammatory disease development, progression, and resolution requires investigation.
Purpose of the Study:
- To investigate the immunoregulatory role of RELM-alpha in T helper type 2 (Th2) cytokine-dependent lung inflammation.
- To characterize the impact of RELM-alpha deficiency on the development and severity of allergic lung inflammation.
- To elucidate the mechanisms by which RELM-alpha modulates immune responses in the context of lung inflammation.
Main Methods:
- Generation of RELM-alpha-deficient (Retnla(-/-)) mice.
- Utilized a mouse model of Schistosoma mansoni (Sm) egg-induced Th2 lung inflammation.
- Assessed lung inflammation, granuloma formation, fibrosis, pulmonary vascularization, and CD4(+) T cell cytokine production.
- Investigated the binding of recombinant RELM-alpha to immune cells and its effect on cytokine production via Bruton's tyrosine kinase (BTK) signaling.
- Evaluated the capacity of Retnla(-/-) AAMacs to promote Th2 cell differentiation.
Main Results:
- Retnla(-/-) mice exhibited exacerbated lung inflammation, increased pulmonary vascularization, larger granulomas, and elevated fibrosis following Sm egg challenge compared to wild-type mice.
- Increased disease severity in Retnla(-/-) mice was associated with elevated expression of Th2 cytokines from CD4(+) T cells.
- Recombinant RELM-alpha inhibited Th2 cytokine production by macrophages and CD4(+) T cells in a BTK-dependent manner.
- AAMacs from Retnla(-/-) mice promoted exaggerated antigen-specific Th2 cell differentiation.
Conclusions:
- RELM-alpha, produced by AAMacs, plays a critical immunoregulatory role in limiting Th2 cytokine-mediated pulmonary inflammation.
- RELM-alpha acts, in part, by regulating CD4(+) T cell responses and inhibiting Th2 cytokine production.
- Loss of RELM-alpha leads to exaggerated allergic lung inflammation and fibrosis, highlighting its protective function.
Related Concept Videos
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Chronic Inflammation: Introduction
Inflammation